anti-CD42a, gpIb, IX antibody product blog
Tags: Antibody; Monoclonal Antibody; CD42a, gpIb, IX; anti-CD42a, gpIb, IX antibody;
The CD42a, gpIb, IX n/a (Catalog #MBS603689) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CD42a, gpIb, IX reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD42a, gpIb, IX can be used in a range of immunoassay formats including, but not limited to, Immunoprecipitation (IP), Flow Cytometry (FC/FACS).Dilution: Flow Cytometry: Neat. Use 10ul of the suggested working dilution to label 10e6 cells or 100ul whole blood. Researchers should empirically determine the suitability of the CD42a, gpIb, IX n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CD42a, gpIb, IX with the following immunoassay(s):
Testing Data (Staining of human peripheral blood platelets with MBS603689.)
Applications: Suitable for use in Flow Cytometry, Immunoprecipitation.
Immunogen: Human red blood cells and platelets. Fusion Partners: Spleen cells from immunized BALB/c mice were fused with cells of the mouse NS1 myeloma cell line. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD42a, gpIb, IX are readily searchable from our website. Different antibodies against the same target such as CD42a, gpIb, IX may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.